Skip to Main Content

Paper Details

Synthetic Lethality Screening Highlights Colorectal Cancer Vulnerability to Concomitant Blockade of NEDD8 and EGFR Pathways.
Cancers (Basel)
5
2021
BRAF, BRAF-mutant and RAS/, CRC, CRC cell, CRC cell lines, Colorectal Cancer, Colorectal cancer, EGFR, NEDD8, NEDD8-activating enzyme, RAF, RAS, drug-target genes, patients, pevonedistat, shRNA, tumor
Author NameAffiliation
Christopher A BristowUT MD Anderson Cancer Center, University of Texas
Christopher A BristowUT MD Anderson Cancer Center, University of Texas
Caterina Marchi??Candiolo Cancer Institute, FPO-IRCCS
Caterina Marchi??University of Torino
Andrea BertottiCandiolo Cancer Institute, FPO-IRCCS
Andrea BertottiUniversity of Torino
Livio TrusolinoCandiolo Cancer Institute, FPO-IRCCS
Livio TrusolinoUniversity of Torino
Enzo MedicoCandiolo Cancer Institute, FPO-IRCCS
Enzo MedicoUniversity of Torino
  • 1 - 10

Datasets

Release 1.2